Literature DB >> 16282542

Plasma adiponectin levels and sonographic phenotypes of subclinical carotid artery atherosclerosis: data from the SAPHIR Study.

Bernhard Iglseder1, Vitolds Mackevics, Andreas Stadlmayer, Gernot Tasch, Gunther Ladurner, Bernhard Paulweber.   

Abstract

BACKGROUND AND
PURPOSE: Adipose tissue produces and secretes a number of bioactive molecules, conceptualized as adipocytokines. Adiponectin has been identified as one of the adipocytokines, and hypoadiponectinemia was demonstrated in patients with obesity, diabetes mellitus, and coronary artery disease. Whether decreased adiponectin levels are cause or consequence is an important issue in the discussion on the association between adiponectin and atherosclerosis. In the present study, we investigated the association of plasma adiponectin levels with sonographic phenotypes of subclinical atherosclerosis, which may represent different stages of disease as well as common and distinct determinants.
METHODS: A total of 1515 middle-aged healthy white subjects (940 males and 575 females) were included. Common carotid artery intima-media thickness (CIMT) and presence of atherosclerotic plaques were assessed by B-mode ultrasound.
RESULTS: After adjustment for established risk factors, per 1 microg/mL decrease in adiponectin CIMT increased on the average by 3.48 microm in males (95% CI, 1.23 to 5.73 microm) and by 2.39 microm in females (95% CI, 0.50 to 4.27 microm). After dichotomizing adiponectin levels at the median and adjustment for established risk factors, the mean difference of CIMT between subjects with low and high adiponectin levels was 20.42 microm in men (95% CI, 6.80 to 34.04; P=0.003) and 20.75 microm in women (95% CI, 1.08 to 40.42; P=0.039). No significant relationship was found between adiponectin levels and presence of atherosclerotic plaques.
CONCLUSIONS: Our results demonstrate an independent negative association of adiponectin levels and CIMT, whereas no relationship with presence of atherosclerotic plaques was found, thus suggesting hypoadiponectinemia as a risk factor in the development of early atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282542     DOI: 10.1161/01.STR.0000190834.00284.fd

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).

Authors:  Unab I Khan; Dan Wang; Maryfran R Sowers; Peter Mancuso; Susan A Everson-Rose; Philipp E Scherer; Rachel P Wildman
Journal:  Metabolism       Date:  2012-03-22       Impact factor: 8.694

Review 2.  Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation.

Authors:  Oh Young Bang
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

3.  Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA).

Authors:  Christina L Wassel; James S Pankow; Laura J Rasmussen-Torvik; Na Li; Kent D Taylor; Xiuqing Guo; Mark O Goodarzi; Walter R Palmas; Wendy S Post
Journal:  Obesity (Silver Spring)       Date:  2010-10-07       Impact factor: 5.002

4.  Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study.

Authors:  Angelo Scuteri; Marco Orru; Christopher Morrell; Maria Grazia Piras; Dennis Taub; David Schlessinger; Manuela Uda; Edward G Lakatta
Journal:  Atherosclerosis       Date:  2010-12-30       Impact factor: 5.162

5.  The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.

Authors:  Milan Gupta; Hwee Teoh; Mahesh Kajil; Michelle Tsigoulis; Adrian Quan; Manoela Fb Braga; Subodh Verma
Journal:  Exp Clin Cardiol       Date:  2012

6.  Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study.

Authors:  Elaine Hui; Aimin Xu; Wing-Sun Chow; Paul C H Lee; Carol H Y Fong; Stephen C W Cheung; Hung Fat Tse; Ming-Tak Chau; Bernard M Y Cheung; Karen S L Lam
Journal:  Metab Syndr Relat Disord       Date:  2014-09-11       Impact factor: 1.894

7.  Serum level of adiponectin correlated with gender and genotype in patients with chronic hepatitis C.

Authors:  Qing-Hua Meng; Zhong-Hui Duan; Zun-Hui Lin; Hong-Wei Yu; Juan Li; Ya Liu
Journal:  Dig Dis Sci       Date:  2008-09-05       Impact factor: 3.199

8.  Adipokines and Subclinical Cardiovascular Disease in Post-Menopausal Women: Study of Women's Health Across the Nation.

Authors:  Susan A Everson-Rose; Emma J M Barinas-Mitchell; Samar R El Khoudary; Hsin-Hui Huang; Qi Wang; Imke Janssen; Rebecca C Thurston; Elizabeth A Jackson; Melissa E Lewis; Carrie Karvonen-Gutierrez; Peter Mancuso; Carol A Derby
Journal:  J Am Heart Assoc       Date:  2021-03-27       Impact factor: 5.501

Review 9.  Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.

Authors:  Lavinia Woodward; Ioannis Akoumianakis; Charalambos Antoniades
Journal:  Br J Pharmacol       Date:  2016-10-19       Impact factor: 8.739

10.  The association of carotid intima media thickness with retinol binding protein-4 and total and high molecular weight adiponectin in type 2 diabetic patients.

Authors:  Masoumeh Mansouri; Ramin Heshmat; Ozra Tabatabaei-Malazy; Farshad Sharifi; Zohreh Badamchizadeh; Sudabeh Alatab; Kobra Omidfar; Hossein Fakhrzadeh; Bagher Larijani
Journal:  J Diabetes Metab Disord       Date:  2012-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.